Special Issue "Drug Delivery and Antimicrobial Agents"
Deadline for manuscript submissions: closed (31 August 2016).
Interests: chitosan and chitosan conjugates; synthesis; structure activity relationship (SAR); spectroscopy; antimicrobial chitosan conjugates and natural compound derivatives; photochemistry; NMR analysis; nanomedicine; nanoparticles; regenerative medicine; antimicrobial activity; absorption enhancers; photodynamic therapy; cancer therapy; mathematical modeling and design of experiment (DOE)
Special Issues and Collections in MDPI journals
This Special Issue, “Drug Delivery and Antimicrobial Agents”, will cover a selection of recent research topics and current review articles in related to the drug delivery of antimicrobial agents. Original research papers, review articles, and commentaries are all welcome.
Microbes existed billions of year before the first humans walked on the face of the Earth. We are dependent on a symbiotic relationship with microorganisms, but microbes have also been the leading cause sickness and death throughout the history of mankind. This peril was, however, largely overcome by the introduction of vaccines and antibiotics in the late 19th and early 20th century. Now, the balance in our coexistence with microbes is shifting again. Widespread, and often unwise, use of antibiotic drugs and disinfectants has led to the evolution of highly resistant strains of bacteria and other microbes against which much of our current arsenal is useless. Therefore, science must again rise to this challenge, and find new ways to overcome this remerging threat.
Resistance is often caused by increased efflux of antibiotics or by the ability of microorganisms to modify and neutralize the antimicrobial agent. Bacteria forming biofilms or hiding in intracellular niches are also highly resistant to treatment. New innovations in delivery are needed to overcome these challenges. In this respect, the emerging field of nanomedicine is expected to make an important contribution. Improved delivery and formulation will also be important to increase the utility of macromolecular agents and natural biocides.
Dr. Már Másson
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- vaccine delivery
- local delivery
- topical treatment